Cargando…

Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target

It is now well-established that sphingosine kinase 1 (SK1) plays a significant role in breast cancer development, progression, and spread, whereas SK1 knockdown can reverse these processes. In breast cancer cells and tumors, SK1 was shown to interact with various pathways involved in cell survival a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshaker, Heba, Thrower, Hannah, Pchejetski, Dmitri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098968/ https://www.ncbi.nlm.nih.gov/pubmed/32266132 http://dx.doi.org/10.3389/fonc.2020.00289

Ejemplares similares

Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting
por: Alshaker, Heba, et al.
Publicado: (2019)

Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors
por: Alshaker, Heba, et al.
Publicado: (2018)

Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1
por: Alshaker, Heba, et al.
Publicado: (2017)

Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway
por: Alshaker, Heba, et al.
Publicado: (2014)

Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1
por: Alshaker, Heba, et al.
Publicado: (2016)

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
por: Pchejetski, Dmitri, et al.
Publicado: (2015)

New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
por: Alshaker, Heba, et al.
Publicado: (2017)

Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer
por: Wang, Qi, et al.
Publicado: (2017)

Monocytes acquire prostate cancer specific chromatin conformations upon indirect co-culture with prostate cancer cells
por: Alshaker, Heba, et al.
Publicado: (2022)

Bradycardia and syncope as sole manifestations of a cranial lesion: a case report
por: Pchejetski, Dmitri, et al.
Publicado: (2020)

A case of severe dry eye disease with corneal melting as presenting complaint of acute myeloid leukaemia
por: Pchejetski, Dmitri, et al.
Publicado: (2021)

Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma
por: Alshaker, Heba, et al.
Publicado: (2015)

The emerging role of FTY720 (Fingolimod) in cancer treatment
por: White, Christopher, et al.
Publicado: (2016)

An unusual case of disseminated intravascular coagulation
por: Pchejetski, Dmitri, et al.
Publicado: (2017)

Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers
por: Pyne, Susan, et al.
Publicado: (2012)

Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection
por: Nunes, J, et al.
Publicado: (2012)

Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
por: Gupta, Preeti, et al.
Publicado: (2021)

Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment
por: Rodriguez, Yamila I., et al.
Publicado: (2016)

Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia
por: Sarapura Martinez, Valeria J., et al.
Publicado: (2023)

Sphingosine kinase 1 as an anticancer therapeutic target
por: Gao, Ying, et al.
Publicado: (2015)

Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups
por: Alshaker, Heba, et al.
Publicado: (2021)

Drugging Sphingosine Kinases
por: Santos, Webster L., et al.
Publicado: (2014)

Construction and Identification of New Molecular Markers of Triple-Negative Breast Cancer Stem Cells
por: Liu, Tingting, et al.
Publicado: (2021)

Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer
por: Khoury, Katia, et al.
Publicado: (2020)

Does the Sphingosine 1-Phosphate Receptor-1 Provide a Better or Worse Prognostic Outcome for Breast Cancer Patients?
por: Pyne, Nigel J., et al.
Publicado: (2018)

Cardiovascular Effects of Pharmacological Targeting of Sphingosine Kinase 1
por: Józefczuk, Ewelina, et al.
Publicado: (2020)

The Relationship of Sphingosine Kinase 1 With Pyroptosis Provides a New Strategy for Tumor Therapy
por: Wang, Xianwang, et al.
Publicado: (2020)

Potential of a sphingosine 1-phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment
por: Tanaka, Yuko, et al.
Publicado: (2022)

The Importance of Sphingosine Kinase in Breast Cancer: A Potential for Breast Cancer Management
por: Patel, Dutt S, et al.
Publicado: (2021)

The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC
por: Lee, Cheng‐Fan, et al.
Publicado: (2022)

Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells
por: Hii, Ling-Wei, et al.
Publicado: (2021)

Structure–Activity Relationships and Molecular Modeling of Sphingosine Kinase Inhibitors
por: Baek, Dong Jae, et al.
Publicado: (2013)

Diacylglycerol Kinase Alpha in Radiation-Induced Fibrosis: Potential as a Predictive Marker or Therapeutic Target
por: Liu, Chun-Shan, et al.
Publicado: (2020)

New Advances in Targeted Therapy of HER2-Negative Breast Cancer
por: An, Junsha, et al.
Publicado: (2022)

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021)

Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer
por: Ochnik, Aleksandra M., et al.
Publicado: (2017)

Targeting sphingosine kinase 1 with LNA oligonucleotides in gastric cancer
por: Füreder, Thorsten, et al.
Publicado: (2008)

The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways
por: Ishay, Yuval, et al.
Publicado: (2021)

Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma
por: Li, Wenhua, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qenqn79nurt1sg3jbju6f9kit8